Company
New York
Every investor coverage indicates participated in a round Memorial Sloan Kettering Cancer Center raised.
Companies Memorial Sloan Kettering Cancer Center acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Memorial Sloan Kettering Cancer Center. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Fidji Simo, who left OpenAI to cofound ChronicleBio, which has raised $20 million to use AI and biological data to subtype chronic illnesses like POTS and long COVID and rescue shelved drugs.
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Cut Through Venture·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·Forbes Australia·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com·Forbes Australia